Alzain Mohammed, Daghistani Hussam, Shamrani Taghreed, Almoghrabi Yousef, Daghistani Yassir, Alharbi Ohood S, Sait Ahmad M, Mufrrih Mohammed, Alhazmi Wafaa, Alqarni Mona Abdulrahman, Saleh Bandar Hasan, Zubair Manal A, Juma Noha A, Niyazi Hatoon A, Niyazi Hanouf A, Halabi Waiel S, Altalhi Rawan, Kazmi Imran, Altayb Hisham N, Ibrahem Karem, Alfadil Abdelbagi
Department of Biochemistry, faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Infect Drug Resist. 2025 Aug 27;18:4385-4426. doi: 10.2147/IDR.S514825. eCollection 2025.
Antimicrobial peptides (AMPs) are short protein fragments that function as an innate immune response across diverse life forms. Structurally, AMPs exhibit diverse configurations, including α-helical, β-sheet, mixed, and random-coil forms, enabling a variety of mechanisms to combat pathogens. The mechanisms of action of AMPs encompass membrane disruption and inhibition of critical cellular processes, highlighting their broad-spectrum activity against bacteria, fungi, viruses, and parasites. AMP activity extends to anti-tumor and anti-HIV activities, further emphasizing their therapeutic potential. Purifying AMPs from natural sources can be challenging due to posttranslational processing. Fortunately, chemical synthesis has the advantage of producing high yield and pure AMPs, but the reaction efficiency diminishes as the molecular weight of peptides increases. Advances in computational tools and curated databases have further accelerated AMP discovery and engineering. While commercially available AMP-based antibiotics and in vivo efficacy against multidrug-resistant bacteria demonstrate their clinical relevance, several limitations still hinder the widespread use of AMPs such as low stability and toxicity to human cells. This review provides a comprehensive overview of AMP origins, characteristics, mechanisms, applications, and future prospects in combating infectious diseases with a particular focus on the clinical applicability of AMPs and their prospects as potent alternative to traditional antibiotics.
抗菌肽(AMPs)是短的蛋白质片段,在多种生命形式中作为一种先天性免疫反应发挥作用。在结构上,抗菌肽呈现出多种构型,包括α-螺旋、β-折叠、混合和无规卷曲形式,从而具备多种对抗病原体的机制。抗菌肽的作用机制包括膜破坏和对关键细胞过程的抑制,突出了它们对细菌、真菌、病毒和寄生虫的广谱活性。抗菌肽的活性还扩展到抗肿瘤和抗HIV活性,进一步强调了它们的治疗潜力。由于翻译后加工的原因,从天然来源纯化抗菌肽可能具有挑战性。幸运的是,化学合成具有产生高产量和纯抗菌肽的优势,但随着肽分子量的增加,反应效率会降低。计算工具和精心策划的数据库的进展进一步加速了抗菌肽的发现和工程设计。虽然基于抗菌肽的商业可用抗生素以及对多重耐药细菌的体内疗效证明了它们的临床相关性,但一些局限性仍然阻碍了抗菌肽的广泛使用,例如稳定性低和对人类细胞有毒性。本综述全面概述了抗菌肽的起源、特性、机制、应用以及在对抗传染病方面的未来前景,特别关注抗菌肽的临床适用性及其作为传统抗生素有效替代品的前景。